publicFounded 2011
Absci Corporation
Funding Summary
Total Funding
$500M+
Latest Valuation
~$500M (public market cap)
About
Combines generative AI with proprietary wet lab validation (SoluPro) for de novo antibody design, reducing drug discovery from years to months.
platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →